SereNeuro Therapeutics
SereNeuro Therapeutics is a Baltimore-based company in biotechnology, listed in Section 1 of the Raise Track Update of 2026-10-06.
- Industry
- biotechnology
- Location
- Baltimore, MD
About
SereNeuro Therapeutics is listed in Section 1 of the Raise Track Update of 2026-10-06, which gives the round as Undisclosed (Pre-Seed). Investors named in the issue: not disclosed in the issue. The issue describes the company this way: A Baltimore, MD-based biotechnology company developing non-opioid therapies for pain raised an undisclosed amount in pre-seed funding. The company intends to use the funds to advance its lead program, SN101, toward Investigational New Drug (IND)-enabling activities and support its second program, SN102.
This page is not indexed by search engines yet. It is promoted once a second source, separate from the newsletter, confirms the round.
Funding history
| Round | Date | Amount | Lead |
|---|---|---|---|
| Pre-Seed 2026 | 2026-10-06 |
Sources
Last verified:
- https://www.finsmes.com/2026/10/sereneuro-therapeutics-closes-pre-seed-funding.html
Type: reputable publication. Accessed 2026-10-12.
Article linked from the Raise Track Update for 2026-10-06. - https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-06/
Type: other verified public source. Accessed 2026-10-12.
Raise Track Update for 2026-10-06, Section 1. Lists SereNeuro Therapeutics at Undisclosed (Pre-Seed) with investors: undisclosed.